Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;76(2):222-7.
doi: 10.1016/j.ejrad.2009.06.007. Epub 2009 Jul 7.

Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical CT features with pathologic findings

Affiliations

Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical CT features with pathologic findings

Yu Liu et al. Eur J Radiol. 2010 Nov.

Abstract

Objective: To evaluate the CT features of intraductal papillary mucinous neoplasms of the pancreas (IPMNs), and to compare with pathological findings in order to identify CT features that can be helpful in differentiating benign IPMNs from malignant IPMNs.

Materials and methods: The CT findings in 25 patients were reviewed for tumor location, tumor type, dilatation of the main pancreatic duct (MPD), MPD involvement, mural node or solid attenuating component, tumor size in branch duct or mixed duct type, dilatation of common bile duct (CBD) and invasion of surrounding structures. The data was subjected to Chi-Square Tests or Fisher's Exact Test using SPSS13.0 software with p value<0.05 indicating significant statistical difference.

Results: Presence of mural node or solid enhancing component, size of mural node or solid enhancing component ≥7mm, dilatation of CBD was more common in malignant IPMNs (p<0.05). None of tumor location, tumor type, dilatation of MPD, MPD involvement, tumor size, and invasion of surrounding structures was statistically significant in differentiating benign from malignant IPMNs.

Conclusions: CT features suggestive of malignant or invasive IPMNs include presence of mural node or solid enhancing component, size of mural node or solid enhancing component ≥7mm, and dilatation of CBD.

PubMed Disclaimer

Publication types

LinkOut - more resources